Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
295
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Krystal Biotech Inc market cap is $9.05B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Krystal Biotech Inc 52 week high is $382.54 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Krystal Biotech Inc 52 week low is $202.99 as of November 17, 2026.
Krystal Biotech Inc stock price today is $297.90.
Krystal Biotech Inc stock price yesterday was $305.23.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Krystal Biotech Inc's P/E ratio is 40.45.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Krystal Biotech Inc P/B ratio is 6.1488.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Krystal Biotech Inc 50-day moving average is $325.56.